DD India·4 min read·medium
India Gets Its First Approved Dengue Vaccine; Qdenga Cleared for Individuals Aged 4-60
D
DD India
✦AI Summary
India has approved the use of Qdenga, a dengue vaccine developed by Takeda, for individuals aged 4 to 60. The vaccine has already been cleared in 42 countries and is supported by extensive global clinical trials.
In a significant step towards strengthening India’s fight against dengue, the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation to the country’s first dengue vaccine, Qdenga®, for the prevention of dengue disease in individuals aged 4 to 60 years.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in